THERIVA BIOLOGICS INC (TOVX) Stock Cash Flow
NYSEARCA:TOVX - NYSE Arca - US87164U5083 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.81M | -25.65M | -18.35M | -19.69M | -14.27M | |||
| Depreciation Amortization | 124.00K | 137.00K | 135.00K | 90.00K | 90.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | -1.64M | -1.43M | N/A | |||
| Change In Working Capital | 902.00K | 1.18M | 2.70M | -620.00K | 880.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 6.97M | 7.40M | -1.84M | 2.57M | 420.00K | |||
| OPERATING CASH FLOW | -16.81M | -16.94M | -19.00M | -19.08M | -12.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.00K | -202.00K | -120.00K | -10.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | -4.28M | N/A | |||
| INVESTING CASH FLOW | N/A | -1.00K | -202.00K | -4.40M | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.28M | -67.00K | -75.00K | -1.38M | N/A | |||
| Stock Issued/Repurchased | N/A | 5.56M | 2.22M | 2.45M | 74.00M | |||
| Other Financing Activity | N/A | 0.00 | -1.52M | -3.00M | N/A | |||
| FINANCING CASH FLOW | 8.57M | 5.50M | 625.00K | -1.93M | 74.00M | |||
| Exchange Rate Effect | -1.00K | -132.00K | -33.00K | -30.00K | N/A | |||
| CHANGE IN CASH | -8.25M | -11.57M | -18.61M | -25.44M | 61.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.81M | -16.94M | -19.00M | -19.08M | -12.89M | |||
| Capital Expenditure | N/A | -1.00K | -202.00K | -120.00K | -10.00K | |||
| FREE CASH FLOW | -16.81M | -16.94M | -19.20M | -19.20M | -12.90M | |||
All data in USD